To investigate the efficacy and safety of laprazole sodium for injection in the treatment of peptic ulcer with upper gastrointestinal bleeding.
160 Patients with peptic ulcer complicated with gastrointestinal bleeding admitted to the Medical Oncology of Qionghai People's Hospital from June 2018 to June 2020 were prospectively enrolled and randomly divided into control group and observation group with 80 patients each. The control group was treated with omeprazole sodium for injection and the observation group was treated with laprazole sodium for injection. The effective hemostasis rate of the two groups was observed 72 h after treatment. The proportion of patients undergoing blood transfusion and endoscopic or surgical treatment for gastrointestinal bleeding during the treatment period were observed. The safety of the two groups was evaluated.
The effective hemostasis rate at 72 h was 93.75% in the observation group and 92.50% in the control group, and there was no significant difference between the two groups (P>0.05). The effective hemostatic rates of the low-risk subgroup were 94.87% and 94.59% in the observation group and the control group, and the effective hemostatic rates of the high-risk subgroup were 92.68% and 90.69%, respectively, with no statistical significance between the two groups (P>0.05). During the treatment, 1 high-risk patient in both the observation group and the control group changed to endoscopic hemostasis; There was no recurrence of bleeding in both groups within 1 week after treatment. There were 5 patients (6.25%) in the observation group receiving blood transfusion, and 3 patients (3.75%) in the control group receiving blood transfusion, and there was no statistical significance between the two groups (P>0.05). The overall incidence of treatment safety in the observation group was 5.00%, lower than that in the control group (15.00%), and the difference was statistically significant (P<0.05).
Eprazole sodium for injection is an ideal drug for the treatment of peptic ulcer complicated with bleeding, which is suitable for clinical application.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |